Back to UBS Group AG UBS Group AG

XLOXLO
2 quarters

Position history for UBS Group AGUBS Group AG's holdings in XILIO THERAPEUTICS INC

UBS Group AG holds 14 shares of XLO (XILIO THERAPEUTICS INC), worth $134 as of 2026-Q2. The position was decreased (-99.7% shares).

Current Value

$134

Current Shares

14

Total Value Change

-$33,826

Total Shares Change

-4,024

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
14
-99.7%
$1340.0%$9.58
0
2026-Q1
New
4,038
-
$33,9600.0%$8.41
30

Other major holders of XLO: VANGUARD CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used